Recruiting NA INTERVENTIONAL 2-arm NCT05811195

Comparison of Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Oncology Patients

Comparison of Two Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Pediatric and Adolescent Oncology Patients: a Randomized, Controlled, Blinded Clinical Trial

Sponsor: Federal University of Rio Grande do Sul

Conditions Chemotherapeutic Toxicity Childhood Cancer Oral Mucositis

Interventions Diode Semiconductor, Duo Gemini laser

Updated 4 times since 2023 Last updated: May 9, 2024 Started: Mar 10, 2023 Primary completion: Apr 1, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Chemotherapeutic Toxicity and Childhood Cancer and is currently actively recruiting participants. Federal University of Rio Grande do Sul leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Recruiting NA
May 2023 — Jun 2024 [monthly]

Recruiting NA

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal University of Rio Grande do Sul
Hospital A.C. Camargo

Data source: Federal University of Rio Grande do Sul

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil